Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties
- PMID: 25744513
- DOI: 10.3109/14756366.2014.986118
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties
Abstract
A series of new Schiff's bases was obtained from the sulfanilamide semicarbazone (4-aminosulfonylphenyl semicarbazide) and aromatic/heterocyclic aldehydes. The new compounds were designed to incorporate moieties known to induce effective inhibitory activity against carbonic anhydrase (CA, EC 4.2.1.1) isoforms involved in crucial physiologic or pathologic processes such as the cytosolic CA I and II or the transmembrane, tumor-associated CA IX and XII: the compounds were medium potency - weak CA I inhibitors, highly effective, low nanomolar CA II inhibitors, but few of them inhibited effectively CA IX and XII. This may probably due to the long spacer between the sulfamoylphenyl and imine fragments of the molecules, which probably induces a highly flexible conformation of the inhibitor bound to the active site of the enzyme, with destabilizing effects for the adduct. The detailed structure activity relationship for this class of inhibitors is discussed.
Keywords: Carbonic anhydrase; Schiff’s base; cytosolic/tumor-associated enzymes; isoform-selective inhibitor; sulfonamide.
Similar articles
-
Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.Bioorg Med Chem Lett. 2005 Jun 15;15(12):3096-101. doi: 10.1016/j.bmcl.2005.04.055. Bioorg Med Chem Lett. 2005. PMID: 15908204
-
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.Bioorg Med Chem. 2014 Nov 1;22(21):5883-90. doi: 10.1016/j.bmc.2014.09.021. Epub 2014 Sep 21. Bioorg Med Chem. 2014. PMID: 25267005
-
Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.Bioorg Med Chem. 2015 Oct 15;23(20):6573-80. doi: 10.1016/j.bmc.2015.09.022. Epub 2015 Sep 15. Bioorg Med Chem. 2015. PMID: 26422787
-
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.Expert Opin Investig Drugs. 2018 Dec;27(12):963-970. doi: 10.1080/13543784.2018.1548608. Epub 2018 Nov 22. Expert Opin Investig Drugs. 2018. PMID: 30426805 Review.
-
Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).Expert Opin Ther Pat. 2016 Aug;26(8):947-56. doi: 10.1080/13543776.2016.1203904. Epub 2016 Jul 11. Expert Opin Ther Pat. 2016. PMID: 27387065 Review.
Cited by
-
Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: a decade of structural and therapeutic insights.RSC Adv. 2024 Nov 12;14(48):35769-35970. doi: 10.1039/d4ra06290f. eCollection 2024 Nov 4. RSC Adv. 2024. PMID: 39534850 Free PMC article. Review.
-
Aryl-4,5-dihydro-1H-pyrazole-1-carboxamide Derivatives Bearing a Sulfonamide Moiety Show Single-digit Nanomolar-to-Subnanomolar Inhibition Constants against the Tumor-associated Human Carbonic Anhydrases IX and XII.Int J Mol Sci. 2020 Apr 9;21(7):2621. doi: 10.3390/ijms21072621. Int J Mol Sci. 2020. PMID: 32283813 Free PMC article.
-
Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors.J Enzyme Inhib Med Chem. 2020 Dec;35(1):289-297. doi: 10.1080/14756366.2019.1695791. J Enzyme Inhib Med Chem. 2020. PMID: 31797703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources